Fresenius Medical Care (NYSE: FMS) reported Q3 EPS of $1.09, $0.57 better than the analyst estimate of $0.52. Revenue for the quarter came in at $4.6 billion versus the consensus estimate of $4.55 billion.

For earnings history and earnings-related data on Fresenius Medical Care (FMS) click here.